Background stories of how others approached and experienced their European Horizon funding trajectory.
The Miricle project, ‘Mine Risk Clearance for Europe’, obtained funding under the European Defence Industrial Development programme call ‘Underwater control contributing to resilience at sea’. The main objective of the project was to achieve a European and sovereign capacity in future mine warfare and create a path for the next generation ‘made in Europe’ countermeasure solutions. In order to realise this objective, Miricle addressed various stages: studies, design, prototyping and testing. These stages inter alia included the successful testing of an XL Unmanned Underwater Vehicle, a protototyped mine disposal system and multiple innovative systems to detect buried mines. Flanders Marine Institute (VLIZ), was one of the five Belgian partners in the consortium. Within the project, VLIZ was able to forward its research on the acoustic imaging of the seabed to spatially map and visualize buried structures and objects - in this case buried mines - in the highest possible detail. VLIZ also led the work on ‘Port and Offshore Testing’, building on the expertise of the institute in the field of marine operations and technology.
Read the full article for detailsThe METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.